2015
DOI: 10.1002/14651858.cd010882.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological interventions for unilateral spatial neglect after stroke

Abstract: The quality of the evidence from available RCTs was very low. The effectiveness and safety of pharmacological interventions for USN after stroke are therefore uncertain. Additional large RCTs are needed to evaluate these treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 80 publications
0
13
0
Order By: Relevance
“…The research question we investigated in our review has been addressed before from different perspectives using our population of interest but with a different intervention (i.e., pharmacological intervention) [ 7 ] or investigating either the intervention or the control arms explored in this review but with a different population (e.g., idiopathic Parkinson's disease (IPD) [ 48 ], panic disorder in adults [ 66 ], or amyotrophic lateral sclerosis or motor neuron disease) [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The research question we investigated in our review has been addressed before from different perspectives using our population of interest but with a different intervention (i.e., pharmacological intervention) [ 7 ] or investigating either the intervention or the control arms explored in this review but with a different population (e.g., idiopathic Parkinson's disease (IPD) [ 48 ], panic disorder in adults [ 66 ], or amyotrophic lateral sclerosis or motor neuron disease) [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pharmacological interventions such as dopamine and noradrenergic agonists or procholinergic treatment have been used in people affected by USN after stroke, but the evidence derived from a Cochrane systematic review that included only two available RCTs was very low and inconclusive [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…There already exists an extensive literature on psychopharmaceuticals in the treatment of attention deficits, and a full review is beyond the scope of this article. Pharmaceuticals that primarily target the noradrenergic system (e.g., guanfacine) or catecholamine system in general (e.g., methylphenidate, amphetamine, modafinil) have consistently been shown to improve wakefulness and sustained attention in a variety of populations, including children and adults with ADHD, patients suffering from hemispatial neglect, and healthy adults . Research suggest that the effects of therapeutic doses of these pharmaceuticals are relatively specific to the prefrontal cortex, strengthening its functioning and interactions with other brain regions .…”
Section: Modulating Sustained Attention Abilitymentioning
confidence: 99%
“…The aims of the current review were (1) to give an overview of human studies investigating pharmacotherapy to ameliorate VSN symptoms and (2) to evaluate the quality of those studies. These aims parallel those made in a Cochrane review 39 on the pharmacological treatment of VSN, published shortly before we completed the current review. However, several differences positively distinguish the current review from the Cochrane review.…”
Section: Objectives and Distinctivenessmentioning
confidence: 76%